Treating To Target in Type 2 Diabetes : Home page

Treating To Target in Type 2 Diabetes

Home page
The Treating To Target in Type 2 diabetes (4-T) study is a three-year, multi-centre, open-label, randomised, parallel-group trial comparing the safety and efficacy of three different analogue insulin treatment regimens in 700 participants with Type 2 diabetes inadequately controlled by oral therapy. Principal Investigator: Professor Rury Holman Co-Investigators: Dr Jonathan Levy, Dr Andrew Farmer and Professor Melanie Davies Trial Manager: Julie Darbyshire Trial Administrator: Rachel Roberts ISRCTN number: 51125379 News Show all No recent news articles exist The trial is funded by an unrestricted educational grant from Novo Nordisk


4-T Office, Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LJ Tel: +44 (0)1865 857239 Fax: +44 (0)1865 857248 Email: 4-T@dtu.ox.ac.uk Home \| Freedom of Information \| Privacy Policy \| Copyright \| Accessibility \| OCDEM \| NDM \| Oxford University

Home page